|
2024
|
Invention
|
Antibody-drug conjugate targeting antigenic epitope polypeptide, and use thereof. Provided is a u... |
|
|
Invention
|
Crystal form of bicyclic compound and preparation method therefor. The present invention relates ... |
|
|
Invention
|
Brm inhibitor and pharmaceutical composition and use thereof. The present invention relates to a ... |
|
|
Invention
|
Multispecific antibody and use thereof. Provided are a multispecific antibody and the use thereof... |
|
|
Invention
|
Anti-tt3 humanized antibody and use thereof. Provided are an anti-TT3 humanized antibody and the ... |
|
|
Invention
|
Humanized anti-cd3 antibody and use thereof. Provided are a humanized anti-CD3 antibody and the u... |
|
2023
|
Invention
|
Compound targeting pan-kras protein degradation agent and use thereof. A compound targeting a pan... |
|
|
Invention
|
Method for diagnosing and treating rdaa positive disease, and kit. A method for diagnosing and/or... |
|
|
Invention
|
Macrocyclic compound, pharmaceutical composition thereof, and use thereof. The present invention ... |
|
|
Invention
|
Method for diagnosis and treatment of rdaa-positive disease, and kit. The present invention provi... |
|
|
Invention
|
Method and kit for diagnosis and treatment of rdaa-positive diseases. Provided in the present dis... |
|
|
Invention
|
Heteroarylopiperidine derivative, and pharmaceutical composition and use thereof. The present inv... |
|
|
Invention
|
Kras g12d inhibitor and application thereof in medicine. Provided are a compound of formula (I), ... |
|
|
Invention
|
Macrocyclic compound and pharmaceutical composition and use thereof. The present invention relate... |
|
|
Invention
|
Hpk1 inhibitor and medical use thereof. The present invention relates to a compound represented b... |
|
|
Invention
|
Ezh2 inhibitor and use thereof in medicine. Provided is a compound having a structure of formula ... |
|
|
Invention
|
Mutant idh1 and idh2 inhibitor and application thereof. Disclosed are a compound represented by f... |
|
|
Invention
|
Crystal form of pyridazine derivative, and preparation method therefor and use thereof. The prese... |
|
|
Invention
|
Pharmaceutical composition and method for preparing active ingredient compound thereof. The prese... |
|
|
Invention
|
Kras g12d degradation agent and medical use thereof. Disclosed are a compound having an X-Y-Z str... |
|
|
Invention
|
Use of benzimidazole derivative or salt thereof in treatment of leukemia. Provided in the present... |
|
2022
|
Invention
|
Crystal of pyrazolopyrimidinone compound and salt thereof. The present invention relates to a cry... |
|
|
Invention
|
Kras g12d inhibitor and use in medicine. Provided is a compound shown in formula (I), a stereoiso... |
|
|
Invention
|
Bicyclic compound and application thereof. The present invention relates to a compound as shown i... |
|
|
Invention
|
Kras g12d inhibitors and use thereof in medicine. Provided are compounds represented by formula (... |
|
|
Invention
|
Bispecific antibody and application thereof.
Provided are a bispecific antibody and use thereof.... |
|
|
Invention
|
Bispecific antibody and use thereof. Provided are a bispecific antibody and use thereof. The bisp... |
|
|
Invention
|
Bispecific antibody and application thereof. A bispecific antibody and an application thereof are... |
|
|
Invention
|
Salt and crystal form of egfr inhibitor, and composition and use thereof.
The present invention ... |
|
|
Invention
|
Salt and crystal form of egfr inhibitor, and composition and use thereof. The present invention r... |
|
|
Invention
|
Anti-pd-l1 nanobody and use thereof.
Provided are an anti-PD-L1 nanobody and use thereof. The an... |
|
|
Invention
|
Use of ensartinib or salt thereof in treatment of disease carrying met 14 exon skipping mutation.... |
|
|
Invention
|
Pharmaceutical composition of egfr inhibitor and use thereof. The present invention relates to a ... |
|
|
Invention
|
Six-membered aryl or heteroaryl amides, and composition and use thereof.
A compound of formula I... |
|
|
Invention
|
Application of compound in preparation of drug for treating myelofibrosis and related symptoms/si... |
|
|
Invention
|
Polymorph of imidazolidinone compound, preparation method therefor and use thereof.
Disclosed ar... |
|
2021
|
Invention
|
Cd73 inhibitor and application thereof in medicine.
The present invention relates to a novel com... |
|
|
Invention
|
Bicyclic compounds, compositions and use thereof.
The present invention relates to compounds of ... |
|
|
Invention
|
Shp2 inhibitor and composition and application thereof.
A compound (as represented by formula I)... |
|
|
Invention
|
Bicyclic compounds and use thereof.
The present invention relates to a compound as represented b... |
|
|
Invention
|
Shp2 inhibitors, compositions and uses thereof.
Provided are compounds of Formula (I), methods o... |
|
|
Invention
|
Fused ring compound and application thereof in medicine.
The present invention relates to a nove... |
|
|
Invention
|
Salt and crystalline forms of fgfr4 inhibitor and uses thereof.
The present invention relates to... |
|
|
Invention
|
Quinolyl phosphine oxide compound, and composition and application thereof.
The present inventio... |
|
2020
|
Invention
|
Kras g12c inhibitor and pharmaceutical use thereof.
Provided are compounds of formula (I), which... |
|
|
Invention
|
Imidazolidinone compound, preparation method therefor and use thereof.
An imidazolidinone compou... |
|
|
Invention
|
Egfr inhibitor, composition, and method for preparation thereof.
Provided are the compounds of F... |
|
|
Invention
|
Quinazoline compound and pharmaceutical application thereof.
The present invention relates to a ... |
